BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17593342)

  • 1. [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].
    Bschleipfer T; Wagenlehner FM; Weidner W
    Urologe A; 2007 Sep; 46(9):1027-30. PubMed ID: 17593342
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug Points: tachycardia associated with moxifloxacin.
    Siepmann M; Kirch W
    BMJ; 2001 Jan; 322(7277):23. PubMed ID: 11141146
    [No Abstract]   [Full Text] [Related]  

  • 3. Moxifloxacin-induced hypoglycemia in a non-diabetic patient.
    Mandavia DR; Virpariya MM; Patel TK; Tripathi CB
    Curr Drug Saf; 2012 Apr; 7(2):183-5. PubMed ID: 22873504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
    Prescrire Int; 2009 Oct; 18(103):207. PubMed ID: 19882788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.
    Qiao L; Cui X; Li Y
    Eur J Clin Pharmacol; 2011 Jan; 67(1):103-4. PubMed ID: 20809082
    [No Abstract]   [Full Text] [Related]  

  • 6. Moxifloxacin for bacterial keratitis.
    Rosenberg J; Eisen L; Kim J
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
    van Nieuwkoop C; Visser LG; Groeneveld JH; Kuijper EJ
    J Infect; 2008 Feb; 56(2):155-6. PubMed ID: 18083235
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent tendinitis after treatment with two different fluoroquinolones.
    Burkhardt O; Köhnlein T; Pap T; Welte T
    Scand J Infect Dis; 2004; 36(4):315-6. PubMed ID: 15198194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.
    Hoeffken G; Talan D; Larsen LS; Peloquin S; Choudhri SH; Haverstock D; Jackson P; Church D
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):772-5. PubMed ID: 15605184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.
    Prescrire Int; 2009 Oct; 18(103):206. PubMed ID: 19882787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic anaphylaxis caused by moxifloxacin.
    Sánchez-Morillas L; Rojas Pérez-Ezquerra P; Reaño-Martos M; Laguna-Martínez JJ; Gómez-Tembleque P
    Allergol Immunopathol (Madr); 2010; 38(4):226-7. PubMed ID: 20089346
    [No Abstract]   [Full Text] [Related]  

  • 13. Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study.
    Zhou B; Jiang X; Zhai L; Xiao S; Wang J; Xiao G; Ruan B; Liang C; Ye Q; Hu B; Wang H
    Acta Otolaryngol; 2010 Sep; 130(9):1058-64. PubMed ID: 20235900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial.
    Freitas LL; Soriano E; Muccioli C; Höfling-Lima AL; Belfort R
    Curr Med Res Opin; 2007 Dec; 23(12):3123-30. PubMed ID: 17980093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abstracts of the 6th Moxifloxacin Research Workshop, March 1-2, 2007, Leverkusen, Germany].
    Infection; 2007 Aug; 35 Suppl 1():i-x, 4-73. PubMed ID: 18183639
    [No Abstract]   [Full Text] [Related]  

  • 16. [Novel side effects of moxifloxacin: making a balanced decision again].
    Prins JM; Koopmans RP
    Ned Tijdschr Geneeskd; 2008 Aug; 152(34):1862-4. PubMed ID: 18788675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of moxifloxacin, a new antimicrobial of the fluoroquinolone group in Russia].
    Iakovlev VS; Iakovlev VP
    Antibiot Khimioter; 2007; 52(6):28-35. PubMed ID: 18476472
    [No Abstract]   [Full Text] [Related]  

  • 18. Electroconvulsive therapy and antibiotics: a case report.
    Reti IM; Davydow DS
    J ECT; 2007 Dec; 23(4):289-90. PubMed ID: 18090707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
    Chang CM; Lee NY; Lee HC; Lee IW; Wu CJ; Lin YS; Ko WC
    Ann Pharmacother; 2008 Apr; 42(4):580-3. PubMed ID: 18349304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany].
    Infection; 2012 Aug; 40 Suppl 1():1-71. PubMed ID: 22936293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.